Key questions regarding the SYMPLICITY HTN-3 trial - Authors' reply. Bhatt DL, Bakris GL. Lancet 2023;401:1337-1338.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bhatt DL, Bakris GL. Key questions regarding the SYMPLICITY HTN-3 trial - Authors' reply. Lancet 2023;401:1337-1338.
PMID: 37087166